Company profile: CoreMedic
1.1 - Company Overview
Company description
- Provider of devices for treating heart valve diseases, offering the ChordArt TMVr-System, a catheter-based mitral valve repair solution designed to replace damaged mitral valve chords through a minimally invasive procedure.
Products and services
- Heart Valve Device Development: Architects devices addressing heart valve diseases by creating an innovative, minimally invasive mitral chord replacement concept for MR, originating from the University of Bern spin-out
- Heart Valve Device Manufacturing: Produces devices addressing heart valve diseases, with MR-focused fabrication supporting mitral chord replacement therapies developed by the company since 2012
- ChordArt TMVr-System: Catheter-based product for mitral valve repair that replaces damaged mitral valve chords via a minimally invasive procedure to address mitral valve regurgitation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CoreMedic
Blue Medical
HQ: The Netherlands
Website
- Description: Provider of cardiovascular medical devices, including diamond-coated coronary stents, coronary stent systems, PTCA balloon catheters, and drug eluting solutions, designed and produced in its own production facility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Blue Medical company profile →
Atritech
HQ: United States
Website
- Description: Provider of proprietary technology focused on replacing long-term anticoagulation therapy for patients with non-valvular atrial fibrillation at risk of stroke, including the WATCHMAN Left Atrial Appendage Closure Technology. Private company founded in 2000 and based in Minneapolis, Minnesota.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Atritech company profile →
4C Medical
HQ: United States
Website
- Description: Provider of minimally invasive therapies for structural heart disease, including AltaValve, a transcatheter mitral valve replacement device designed to treat mitral regurgitation by positioning above the native valve, preserving cardiac structures, and accommodating complex anatomies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 4C Medical company profile →
TYRX
HQ: United States
Website
- Description: Provider of medical-pharmaceutical combination devices and resorbable polymeric biomaterials delivering site-specific therapy for multiple surgical markets. Offers PIVIT CRM, a mesh-based pouch with antibacterial agents to protect against microbial colonization of the generator or defibrillator during and immediately after surgical implant; also provides AIGISRx.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TYRX company profile →
BMEYE
HQ: The Netherlands
Website
- Description: Provider of non-invasive cardiovascular monitoring technologies, focused on R&D for finger arterial pressure and cardiac output, offering products such as Finapres, a non-invasive continuous finger arterial pressure technology, serving the Netherlands and international markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BMEYE company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CoreMedic
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CoreMedic
2.2 - Growth funds investing in similar companies to CoreMedic
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CoreMedic
4.2 - Public trading comparable groups for CoreMedic
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →